Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 39Breast Carcinoma In Situ 5Carcinoma, Intraductal, Noninfiltrating 4Rectal Neoplasms 3Ovarian Neoplasms 3Motor Activity 3Endometrial Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Body Weight Changes 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Obesity 2Hereditary Breast and Ovarian Cancer Syndrome 2Depression 2Carcinoma, Renal Cell 2Behavior 2Anxiety Disorders 2Testicular Neoplasms 1Stomach Neoplasms 1Sexuality 1Risk Reduction Behavior 1Penile Neoplasms 1Patient Acceptance of Health Care 1Pancreatic Neoplasms 1Pain 1No Evidence of Disease 1Neoplasms 1Kidney Neoplasms 1Health Behavior 1

Interventions

Mammography 4Magnetic Resonance Spectroscopy 3pembrolizumab 1Vertical Dimension 1Therapeutics 1TKM-080301 1Surveys and Questionnaires 1Sensitivity Training Groups 1Self-Management 1Referral and Consultation 1Quality of Life 1Professional Autonomy 1Patient Positioning 1Paclitaxel 1Methylene Blue 1Mass Screening 1Magnetic Resonance Imaging 1Interviews as Topic 1Interleukin-15 1Gemcitabine 1Exercise 1Drug Delivery Systems 1Doxorubicin 1Counseling 1Blood Specimen Collection 1Biopsy 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Counseling × Breast × Clear all
NCT00712621 2009-11-24

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

American Scitech International

Phase 2 Withdrawn
460 enrolled
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡